Literature DB >> 22978422

Molecular dynamics simulations and structural descriptors of radioisotope glass vectors for in situ radiotherapy.

Jamieson K Christie1, Antonio Tilocca.   

Abstract

The low solubility (high durability) of yttrium aluminosilicate (YAS) glass is one of its most important properties for use in in situ radiotherapy. Simple parameters, such as silica or yttria content or network connectivity, are not sufficient to rationalize the dependence of the solubility on the glass composition observed experimentally. We performed classical molecular dynamics (MD) simulations of eight different YAS glasses of known solubility and analyzed the MD trajectories to identify specific structural features that are correlated and can be used to predict the solubility. We show that the (Si-)O-Si coordination number CN(SiOSi), the yttrium-yttrium clustering ratio R(YY), and the number of intratetrahedral O-Si-O bonds per yttrium atom N(intra) can be combined into a single structural descriptor s = f(CN(SiOSi),R(YY),N(intra)) with a high correlation with the solubility. The parameter s can thus be calculated from MD simulations and used to predict the solubility of YAS compositions, allowing one to adjust them to the range required by radiotherapy applications. For instance, its trend shows that high-silica- and low-yttria-content YAS glasses should be sufficiently durable for the radiotherapy application, although additional clinical considerations may set a lower limit to the yttria content.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22978422     DOI: 10.1021/jp304200f

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  1 in total

1.  Toward a rational design of bioactive glasses with optimal structural features: composition-structure correlations unveiled by solid-state NMR and MD simulations.

Authors:  Renny Mathew; Baltzar Stevensson; Antonio Tilocca; Mattias Edén
Journal:  J Phys Chem B       Date:  2014-01-08       Impact factor: 2.991

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.